Young James Emmett

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$163,500.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Young James Emmett

According to the SEC Form 4 filings, Young James Emmett, being in a position of

  1. Chief Financial Officer at TriSalus Life Sciences, Inc.,
    оver the last 12 months, has bought 30000 shares for $163,500, and sold 0 shares,
    over all time since 2025-01-27, has bought 30000 shares for $163,500, and sold 0 shares.

The largest purchase of all time was on 2025-01-27 and amounted to 24000 shares of TriSalus Life Sciences, Inc. for $129,600.

Biography of Young James Emmett

No biography is available at this moment.

2025-02-05PurchaseTriSalus Life Sciences, Inc.
TLSI
Chief Financial Officer
6,000
0.0208%
$5.65$33,900+5.57%
2025-01-27PurchaseTriSalus Life Sciences, Inc.
TLSI
Chief Financial Officer
24,000
0.0786%
$5.40$129,600+0.19%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.